Cargando…

Sex‐Based Differences in Unrecognized Myocardial Infarction

BACKGROUND: Myocardial infarction is an important cause of morbidity and mortality in both men and women. Atypical or the absence of symptoms, more prevalent among women, may contribute to unrecognized myocardial infarctions and missed opportunities for preventive therapies. The aim of this research...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Ende, M. Yldau, Juarez‐Orozco, Luis Eduardo, Waardenburg, Ingmar, Lipsic, Erik, Schurer, Remco A. J., van der Werf, Hindrik W., Benjamin, Emelia J., van Veldhuisen, Dirk Jan, Snieder, Harold, van der Harst, Pim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670510/ https://www.ncbi.nlm.nih.gov/pubmed/32573316 http://dx.doi.org/10.1161/JAHA.119.015519

Ejemplares similares

The effect of feedback on cardiovascular risk factors on optimization of primary prevention: The PharmLines initiative
por: van der Ende, M. Yldau, et al.
Publicado: (2020)

Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
por: Groot, Hilde E., et al.
Publicado: (2018)

Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

Author Correction: Causal Pathways from Blood Pressure to Larger QRS Amplitudes: a Mendelian Randomization Study
por: Van Der Ende, M. Yldau, et al.
Publicado: (2018)

The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis
por: van der Ende, M. Yldau, et al.
Publicado: (2021)

Predictors of left ventricular remodeling after ST-elevation myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2017)

Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT
por: Hartman, Minke H. T., et al.
Publicado: (2017)

Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial
por: Haver, Vincent G., et al.
Publicado: (2015)

Left ventricular restoration devices post myocardial infarction
por: Hendriks, Tom, et al.
Publicado: (2018)

Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction
por: Bouma, Wobbe, et al.
Publicado: (2016)

Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
por: Al Ali, Lawien, et al.
Publicado: (2023)

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
por: Eppinga, Ruben N., et al.
Publicado: (2016)

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction
por: Al Ali, Lawien, et al.
Publicado: (2016)

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015)

Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial
por: Posma, Rene A., et al.
Publicado: (2015)

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial
por: Lexis, Chris P. H., et al.
Publicado: (2012)

Development and first results of a dedicated chronic total occlusion programme
por: van der Werf, H. W., et al.
Publicado: (2019)

Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?
por: Ties, Daan, et al.
Publicado: (2022)

Contributions of Interactions Between Lifestyle and Genetics on Coronary Artery Disease Risk
por: Said, M. Abdullah, et al.
Publicado: (2019)

Safety and Tolerability of Sodium Thiosulfate in Patients with an Acute Coronary Syndrome Undergoing Coronary Angiography: A Dose-Escalation Safety Pilot Study (SAFE-ACS)
por: de Koning, Marie-Sophie L. Y., et al.
Publicado: (2020)

Genetics and the heart rate response to exercise
por: van de Vegte, Yordi J., et al.
Publicado: (2019)

Multi-task Deep Learning of Myocardial Blood Flow and Cardiovascular Risk Traits from PET Myocardial Perfusion Imaging
por: Yeung, Ming Wai, et al.
Publicado: (2022)

Pre-screening to guide coronary artery calcium scoring for early identification of high-risk individuals in the general population
por: Ties, Daan, et al.
Publicado: (2022)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Prehospital risk stratification in patients with chest pain
por: Sagel, Dennis, et al.
Publicado: (2021)

Statins in the Treatment of Chronic Heart Failure: A Systematic Review
por: van der Harst, Pim, et al.
Publicado: (2006)

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
por: Said, M. Abdullah, et al.
Publicado: (2018)

Sex differences in leukocyte profile in ST-elevation myocardial infarction patients
por: van Blokland, Irene V., et al.
Publicado: (2020)

Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study
por: Groot, Hilde E., et al.
Publicado: (2020)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor Treatment
por: Wang, Siqi, et al.
Publicado: (2021)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

Twenty-Five Novel Loci for Carotid Intima-Media Thickness: A Genome-Wide Association Study in >45 000 Individuals and Meta-Analysis of >100 000 Individuals
por: Yeung, Ming Wai, et al.
Publicado: (2021)

Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
por: van der Harst, Pim, et al.
Publicado: (2018)

Observational and genetic evidence support a relationship between cardiac autonomic function and blood pressure
por: Chen, Zekai, et al.
Publicado: (2023)

Effects of Caffeine on Myocardial Blood Flow: A Systematic Review
por: van Dijk, Randy, et al.
Publicado: (2018)

Unrecognized myocardial infarction by echocardiography in relation to infarct characteristics as assessed by cardiovascular magnetic resonance imaging
por: Jaarsma, Caroline, et al.
Publicado: (2012)

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
por: Lok, Dirk J. A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f8b6rknsivdm7094slho4gje9d